5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols
Key Takeaways
- Slow Vital Capacity (SVC) measures the maximum volume of air exhaled or inhaled slowly without maximal forced effort, preventing dynamic airway collapse in patients with obstructive lung disease.
- Forced Vital Capacity (FVC) requires a maximal, explosive exhalation from Total Lung Capacity (TLC) to Residual Volume (RV) executed with immediate effort and no start hesitation.
- In severe obstructive pulmonary diseases such as emphysema and COPD, the SVC is frequently larger than the FVC (SVC > FVC) due to air trapping caused by high intrathoracic pressure during forced maneuvers.
- The FVC maneuver consists of four distinct physiological phases: rapid maximal inspiration to TLC, explosive blast of exhalation, continuous exhalation for at least 6 seconds (3 seconds in children <10 years), and rapid maximal inhalation back to TLC.
- Proper patient positioning (upright seated in an arm-supported chair with feet flat, nose clip applied, and tight mouthpiece seal without tongue occlusion) is mandatory to eliminate technical artifacts during both FVC and SVC maneuvers.
5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols
Spirometry represents the foundational diagnostic modality in pulmonary function testing. It measures the volume of air an individual can inhale or exhale as a function of time. The two fundamental vital capacity maneuvers evaluated in pulmonary diagnostics are the Forced Vital Capacity (FVC) and the Slow Vital Capacity (SVC) (also referred to as unforced or relaxed vital capacity). Although both maneuvers quantify the maximum volume of air mobilizable between full inspiration (Total Lung Capacity, TLC) and full expiration (Residual Volume, RV), the mechanical execution, pressure dynamics, and clinical indications of FVC and SVC differ significantly.
Mastering the technical performance, patient coaching, and physiological nuances of FVC and SVC testing is essential for the Certified Pulmonary Function Technologist (CPFT). This section details patient preparation, step-by-step execution protocols, mechanics of dynamic airway collapse, and comparative clinical application of both testing methods.
Patient Preparation, Setup, and Ergonomics
To obtain valid, reproducible diagnostic data and ensure patient safety during spirometric testing, the technologist must execute a rigorous pre-test preparation protocol.
Pre-Test Patient Verification and Safety Screen
Before initiating testing, the technologist must verify patient identification, record age, biological sex, height (measured barefoot or in socks), weight, and race/ethnicity to ensure accurate selection of reference (predicted) values. Prior to testing, absolute and relative contraindications must be screened:
- Relative Contraindications (ATS/ERS 2019 — there are no absolute contraindications): acute myocardial infarction within 1 week, systemic hypotension or severe hypertension, significant arrhythmia, noncompensated heart failure, uncontrolled pulmonary hypertension, acute cor pulmonale, clinically unstable pulmonary embolism, syncope with forced expiration or cough, cerebral aneurysm, brain surgery within 4 weeks, recent concussion with symptoms, eye surgery within 1 week, sinus or middle ear surgery or infection within 1 week, pneumothorax, thoracic or abdominal surgery within 4 weeks, late-term pregnancy, and active or suspected transmissible infection. The ordering clinician makes the risk-benefit call, and testing stops if the patient develops pain.
- Pre-Test Withholding of Medications: for bronchodilator responsiveness, hold short-acting beta-agonists (albuterol) 4–6 h, short-acting muscarinic antagonists (ipratropium) 12 h, long-acting beta-agonists (formoterol, salmeterol) 24 h, ultra-long-acting beta-agonists (indacaterol, vilanterol, olodaterol) 36 h, and long-acting muscarinic antagonists (tiotropium, umeclidinium) 36–48 h.
Seating, Posture, and Interface Setup
- Seating: Testing must be performed with the patient seated upright in a sturdy chair with arms, no wheels, and feet flat on the floor. Seating prevents syncope-related falls (which can occur due to increased intrathoracic pressure during forced exhalation) and standardizes diaphragm mechanics.
- Nose Clip: A secure nose clip must be placed on the patient's nose before testing to eliminate unnoticed nasal air leaks during inspiration and exhalation.
- Mouthpiece Seal: The patient must place the mouthpiece inside the mouth above the tongue, biting gently with teeth on the outer rim, and sealing lips tightly around the tube to prevent perioral leaks. The technologist must visually inspect that the tongue does not occlude the lumen of the mouthpiece or bacterial filter.
Slow Vital Capacity (SVC) Testing Protocol
The Slow Vital Capacity (SVC) is the maximum volume of gas that can be exhaled slowly and completely from TLC to RV (Expiratory SVC) or inhaled slowly from RV to TLC (Inspiratory SVC) without maximal forced expiratory effort.
TLC | /
| / \ /
Volume | / \ / <-- Slow, unforced exhalation
| / \ /
RV |__/________\____/
+---------------------> Time
Physiological Rationale: Air Trapping and Dynamic Airway Collapse
In healthy individuals with normal elastic recoil and non-obstructed airways, FVC and SVC are virtually identical ($FVC \approx SVC$). However, in patients with obstructive lung diseases—such as emphysema, chronic bronchitis, asthma, or bronchiectasis—forced expiratory effort generates high positive intrathoracic pressures. This high transmural pressure gradient causes non-cartilaginous, small airways (which lack structural support and have lost elastic recoil) to compress dynamically and close prematurely.
This phenomenon, known as dynamic airway collapse, traps gas behind closed airways, preventing complete lung emptying to Residual Volume. As a result, the measured FVC is artifactually reduced. During an SVC maneuver, because exhalation is performed slowly without explosive muscular force, intrathoracic pressures remain low, small airways remain open longer, and gas emptying is maximized. Consequently, in obstructive lung disease, the SVC is frequently significantly larger than the FVC ($SVC > FVC$).
Step-by-Step Expiratory SVC Protocol
- Tidal Breathing: Attach patient to the spirometer via mouthpiece and nose clip. Observe relaxed tidal breathing until a stable end-expiratory baseline (Functional Residual Capacity, FRC) is established (typically 3–5 steady tidal breaths).
- Maximal Slow Inspiration: Instruct the patient to inhale slowly, deeply, and continuously until their lungs are completely full (TLC).
- Maximal Slow Expiration: Immediately instruct the patient to exhale smoothly, slowly, and continuously—without pushing or straining—until no more air can be exhaled (RV). Exhalation rate should be steady, maintaining a flow rate of approximately 0.5 L/sec, continuing until a 1-second volume plateau is reached.
- Return to Tidal Breathing: Allow the patient to return to normal breathing. Repeat after a brief rest until at least two acceptable SVC maneuvers agreeing within $0.150\text{ L}$ ($150\text{ mL}$) are obtained.
Clinical Application of SVC Data
- FEV1/SVC Ratio: When calculating the ratio to determine airway obstruction, the largest vital capacity (whether SVC or FVC) should be used as the denominator ($FEV1 / VC_{max}$). Using an artifactually low FVC overestimates the $FEV1/VC$ ratio, potentially masking airflow obstruction.
- Reference VC for Sub-Lung Volumes: The SVC provides the true reference vital capacity for calculating Total Lung Capacity ($TLC = FRC + IC$) during helium dilution, nitrogen washout, or body plethysmography.
Forced Vital Capacity (FVC) Testing Protocol
The Forced Vital Capacity (FVC) is the maximum volume of gas that can be exhaled as forcefully and rapidly as possible after a maximal inhalation to TLC.
The Four Physiological Phases of FVC Execution
| Phase | Action | Technical Requirement | Clinical / Coaching Goal |
|---|---|---|---|
| Phase 1: Maximal Inhalation | Rapid, deep inspiration from FRC to TLC | $< 1-2\text{ sec}$ pause at TLC | Full expansion of lungs; avoid prolonged breath-hold at TLC which causes stress relaxation |
| Phase 2: Explosive Blast | Immediate maximal forced exhalation | Back-extrapolation volume ($EV$) $< 0.100\text{ L}$ or $5%\text{ FVC}$ | Maximum expiratory muscle contraction; immediate peak flow ($PEFR$) attainment |
| Phase 3: Sustained Exhalation | Continuous forced exhalation to RV | Duration $\ge 6\text{ sec}$ (adults) or $\ge 3\text{ sec}$ (children $<10\text{ yr}$) | Complete alveolar emptying; reaching expiratory plateau ($< 0.025\text{ L}$ over $1\text{ sec}$) |
| Phase 4: Maximal Inhalation | Rapid re-inhalation back to TLC | Full inspiratory loop flow | Closure of flow-volume loop; verification of full effort and absence of glottic closure |
Step-by-Step FVC Execution Sequence
- Positioning & Baseline: Patient seated upright with nose clip applied, establishing stable tidal breathing.
- Deep Maximal Inhalation: Coach the patient: "Take a deep breath in, as deep as you possibly can, fill your lungs completely!"
- Explosive Expiratory Blast: Without pausing at full inflation, coach aggressively: "BLAST it out! PUSH! HARDER! FAST! Blow, blow, blow!"
- Sustained Expiratory Coaching: Maintain continuous verbal encouragement for a minimum of 6 seconds: "Keep blowing! Keep squeezing! Don't stop! All the way out!"
- Re-Inhalation: Once expiratory plateau or 6 seconds is achieved: "Breathe deep back in! Big breath in!"
Comparative Analysis: FVC versus SVC
Understanding when to emphasize FVC versus SVC is a core diagnostic competency assessed on the CPFT exam. The table below summarizes the key differences between these two vital capacity maneuvers:
| Operational Parameter | Forced Vital Capacity (FVC) | Slow Vital Capacity (SVC) |
|---|---|---|
| Expiratory Effort | Maximal, explosive, rapid effort right from TLC | Smooth, continuous, unforced relaxed effort |
| Intrathoracic Pressure | Extremely high positive intrathoracic pressure | Low, near-normal intrathoracic pressure |
| Small Airway Response | Promotes dynamic airway compression in diseased lungs | Prevents dynamic airway compression; keeps airways open |
| Primary Clinical Purpose | Measures flow rates ($FEV1$, $FEF_{25-75%}$, $PEFR$) and obstruction | Measures true maximum vital capacity volume without air trapping |
| Diagnostic Value in COPD | Frequently smaller ($FVC < SVC$) due to dynamic air trapping | Frequently larger ($SVC > FVC$); provides baseline for lung volumes |
| Repeatability Standard | 2 highest FVCs within $0.150\text{ L}$ ($150\text{ mL}$) | 2 highest SVCs within $0.150\text{ L}$ ($150\text{ mL}$) |
| Execution Limit | Maximum of 8 trials per session due to fatigue | Typically 2–4 trials; low fatigue impact |
Why is the Slow Vital Capacity (SVC) maneuver frequently larger than the Forced Vital Capacity (FVC) maneuver in patients with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)?
Which step represents the correct execution protocol for the expiratory phase of a Forced Vital Capacity (FVC) maneuver?
In evaluating a patient with severe emphysema, the spirometry report shows an FVC of 2.10 L and an SVC of 2.85 L, with an FEV1 of 1.10 L. How should the technologist calculate and interpret the vital capacity ratio?